ANCHOR presentation at ASH 2020
Oncopeptides presented new data from phase 2 ANCHOR combination study in multiple myeloma the 62<sup>nd</sup> American Society of Hematology virtual annual meeting ASH, December 6, 2020. See presentation below.
Go to the home page
-
Change Region
-
Global
-
United States
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at www.oncopeptides-us.com
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our German operations at www.oncopeptides.de
Change Language
-
English
- Swedish
-
-
Loading...
-